相关实验视频

Updated: May 5, 2026

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Published on: September 7, 2010

改善流感检测和治疗的准入:现在是没有处方的奥塞尔塔米维尔的时候了吗?

Kyueun Lee¹, Andrew T Pavia², Janet A Englund^3,4

¹Comparative Health Outcomes Policy and Economics Institute, School of Pharmacy, University of Washington, Seattle, Washington, USA.

The Journal of infectious diseases

|October 16, 2025

概括

奥塞塔米维尔可能会在非处方药 (OTC) 上用于治疗流感,引发了争论. 本评论审查了OTC奥塞尔塔米维尔和替代接入模型的优缺点,并考虑了快速诊断测试.

科学领域:

药理学药理学是指药理学的学科.
传染性疾病传染性疾病
公共卫生公共卫生

背景情况:

欧塞塔米维尔 (oseltamivir) 是一种广泛使用的流感抗病毒药物,现在是一种仿制药.
关于将oseltamivir重新归类为场外 (OTC) 获取的建议是有争议的.
在家诊断测试的可用性增加和流行病的准备性需要重新评估.

研究的目的:

分析使奥塞尔塔米维尔成为OTC药物的益处和风险.
探索改善患者获得快速流感治疗的替代策略.
考虑未来抗病毒流感药物的影响.

主要方法:

关于奥塞塔米维尔有效性和安全性的现有文献的综述.
对OTC可用性的潜在公共卫生影响的分析.
探索将快速流感诊断与抗病毒接入相结合的模型.

主要成果:

非处方奥塞尔塔米维尔可以提高获得及时流感治疗的机会.
潜在的风险包括滥用,抗菌素耐药性和诊断挑战.
替代模型可以平衡可访问性和适当的使用.

结论:

将奥塞尔塔米维尔重新归类为OTC,为流感管理带来了机遇和挑战.
整合快速诊断可能是安全有效的OTC访问的关键.
随着新流感治疗方法的出现,持续评估至关重要.

关键词:

抗病毒药物抗病毒药物流感流感流感流感流感奥塞尔塔米维尔 (oseltamivir) 是一种快速病毒检测快速病毒检测呼吸道病毒的病毒.

更多相关视频

Optimization of a Quantitative Micro-neutralization Assay

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

相关概念视频

Vaccinations

Vaccinations

Influenza

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...